Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

650 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Natural innate and adaptive immunity to cancer.
Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ. Vesely MD, et al. Among authors: smyth mj. Annu Rev Immunol. 2011;29:235-71. doi: 10.1146/annurev-immunol-031210-101324. Annu Rev Immunol. 2011. PMID: 21219185 Review.
Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection.
Kelly JM, Darcy PK, Markby JL, Godfrey DI, Takeda K, Yagita H, Smyth MJ. Kelly JM, et al. Among authors: smyth mj. Nat Immunol. 2002 Jan;3(1):83-90. doi: 10.1038/ni746. Epub 2001 Dec 17. Nat Immunol. 2002. PMID: 11743585
Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice.
Cretney E, Takeda K, Yagita H, Glaccum M, Peschon JJ, Smyth MJ. Cretney E, et al. Among authors: smyth mj. J Immunol. 2002 Feb 1;168(3):1356-61. doi: 10.4049/jimmunol.168.3.1356. J Immunol. 2002. PMID: 11801676
NKT cells - conductors of tumor immunity?
Smyth MJ, Crowe NY, Hayakawa Y, Takeda K, Yagita H, Godfrey DI. Smyth MJ, et al. Curr Opin Immunol. 2002 Apr;14(2):165-71. doi: 10.1016/s0952-7915(02)00316-3. Curr Opin Immunol. 2002. PMID: 11869887 Review.
Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
Seki N, Brooks AD, Carter CR, Back TC, Parsoneault EM, Smyth MJ, Wiltrout RH, Sayers TJ. Seki N, et al. Among authors: smyth mj. J Immunol. 2002 Apr 1;168(7):3484-92. doi: 10.4049/jimmunol.168.7.3484. J Immunol. 2002. PMID: 11907109
A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo.
Kelly JM, Takeda K, Darcy PK, Yagita H, Smyth MJ. Kelly JM, et al. Among authors: smyth mj. J Immunol. 2002 May 1;168(9):4472-9. doi: 10.4049/jimmunol.168.9.4472. J Immunol. 2002. PMID: 11970991
A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.
Crowe NY, Smyth MJ, Godfrey DI. Crowe NY, et al. Among authors: smyth mj. J Exp Med. 2002 Jul 1;196(1):119-27. doi: 10.1084/jem.20020092. J Exp Med. 2002. PMID: 12093876 Free PMC article.
New aspects of natural-killer-cell surveillance and therapy of cancer.
Smyth MJ, Hayakawa Y, Takeda K, Yagita H. Smyth MJ, et al. Nat Rev Cancer. 2002 Nov;2(11):850-61. doi: 10.1038/nrc928. Nat Rev Cancer. 2002. PMID: 12415255 Review. No abstract available.
The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity.
Krenacs L, Smyth MJ, Bagdi E, Krenacs T, Kopper L, Rudiger T, Zettl A, Muller-Hermelink HK, Jaffe ES, Raffeld M. Krenacs L, et al. Among authors: smyth mj. Blood. 2003 May 1;101(9):3590-3. doi: 10.1182/blood-2002-09-2908. Epub 2002 Dec 27. Blood. 2003. PMID: 12506019
Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo.
Tajima A, Tanaka T, Ebata T, Takeda K, Kawasaki A, Kelly JM, Darcy PK, Vance RE, Raulet DH, Kinoshita K, Okumura K, Smyth MJ, Yagita H. Tajima A, et al. Among authors: smyth mj. J Immunol. 2003 Aug 15;171(4):1715-21. doi: 10.4049/jimmunol.171.4.1715. J Immunol. 2003. PMID: 12902470
650 results
Jump to page